Oxygen–Glucose Deprived Peripheral Blood Mononuclear Cells Protect Against Ischemic Stroke
Tóm tắt
Stroke is the leading cause of severe long-term disability. Cell therapy has recently emerged as an approach to facilitate functional recovery in stroke. Although administration of peripheral blood mononuclear cells preconditioned by oxygen–glucose deprivation (OGD-PBMCs) has been shown to be a therapeutic strategy for ischemic stroke, the recovery mechanisms remain largely unknown. We hypothesised that cell–cell communications within PBMCs and between PBMCs and resident cells are necessary for a polarising protective phenotype. Here, we investigated the therapeutic mechanisms underlying the effects of OGD-PBMCs through the secretome. We compared levels of transcriptomes, cytokines, and exosomal microRNA in human PBMCs by RNA sequences, Luminex assay, flow cytometric analysis, and western blotting under normoxic and OGD conditions. We also performed microscopic analyses to assess the identification of remodelling factor-positive cells and evaluate angiogenesis, axonal outgrowth, and functional recovery by blinded examination by administration of OGD-PBMCs after ischemic stroke in Sprague–Dawley rats. We found that the therapeutic potential of OGD-PBMCs was mediated by a polarised protective state through decreased levels of exosomal miR-155-5p, and upregulation of vascular endothelial growth factor and a pluripotent stem cell marker stage-specific embryonic antigen-3 through the hypoxia-inducible factor-1α axis. After administration of OGD-PBMCs, microenvironment changes in resident microglia by the secretome promoted angiogenesis and axonal outgrowth, resulting in functional recovery after cerebral ischemia. Our findings revealed the mechanisms underlying the refinement of the neurovascular unit by secretome-mediated cell–cell communications through reduction of miR-155-5p from OGD-PBMCs, highlighting the therapeutic potential carrier of this approach against ischemic stroke.
Tài liệu tham khảo
Gorelick PB. The global burden of stroke: persistent and disabling. Lancet Neurol. 2019;18(5):417–8. https://doi.org/10.1016/S1474-4422(19)30030-4.
GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429–2437. https://doi.org/10.1056/NEJMoa1804492.
Otsu Y, Namekawa M, Toriyabe M, et al. Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: a literature review. J Neurol Sci. 2020;419:117217. doi: https://doi.org/10.1016/j.jns.2020.117217.
RESCUE BT Trial Investigators, Qiu Z, Li F, Sang H, et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke: the RESCUE BT randomized clinical trial. JAMA. 2022;328(6):543–553. doi: https://doi.org/10.1001/jama.2022.12584.
MacKenzie IER, Moeini-Naghani I, Sigounas D. Trends in endovascular mechanical thrombectomy in treatment of acute ischemic stroke in the United States. World Neurosurg. 2020;138:e839–46. https://doi.org/10.1016/j.wneu.2020.03.105.
Liu X, Ye R, Yan T, et al. Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol. 2014;115:92–115. https://doi.org/10.1016/j.pneurobio.2013.11.007.
Park YJ, Niizuma K, Mokin M, Dezawa M, Borlongan CV. Cell-based therapy for stroke: musing with muse cells. Stroke. 2020;51(9):2854–62. https://doi.org/10.1161/STROKEAHA.120.030618.
Kanazawa M, Miura M, Toriyabe M, et al. Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats. Sci Rep. 2017;7(1):42582. https://doi.org/10.1038/srep42582.
Hatakeyama M, Kanazawa M, Ninomiya I, et al. A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation. Sci Rep. 2019;9(1):16819. https://doi.org/10.1038/s41598-019-53418-5.
Jiang C, Wang J, Yu L, et al. Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia. Behav Brain Res. 2013;250:222–9. https://doi.org/10.1016/j.bbr.2013.05.011.
Ukai R, Honmou O, Harada K, et al. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma. 2007;24(3):508–20. https://doi.org/10.1089/neu.2006.0161.
Kanazawa M, Takahashi T, Ishikawa M, et al. Angiogenesis in the ischemic core: a potential treatment target? J Cereb Blood Flow Metab. 2019;39(5):753–69. https://doi.org/10.1177/0271678X19834158.
Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83(12):4167–71. https://doi.org/10.1073/pnas.83.12.4167.
Jin K, Mao XO, Greenberg DA. Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. J Neurobiol. 2006;66(3):236–42. https://doi.org/10.1002/neu.20215.
Yi JJ, Barnes AP, Hand R, Polleux F, Ehlers MD. TGF-beta signaling specifies axons during brain development. Cell. 2010;142(1):144–57. https://doi.org/10.1016/j.cell.2010.06.010.
Hatakeyama M, Ninomiya I, Kanazawa M. Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res. 2020;15(1):16–9. https://doi.org/10.4103/1673-5374.264442.
Hori E, Hayakawa Y, Hayashi T, et al. Mobilization of pluripotent multilineage-differentiating stress-enduring cells in ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25(6):1473–81. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.12.033.
Kanazawa M, Ninomiya I, Hatakeyama M, Takahashi T, Shimohata T. Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against stroke. Int J Mol Sci. 2017;18(10):2135. https://doi.org/10.3390/ijms18102135.
Hatakeyama M, Ninomiya I, Otsu Y, et al. Cell therapies under clinical trials and polarized cell therapies in pre-clinical studies to treat ischemic stroke and neurological diseases: a literature review. Int J Mol Sci. 2020;21(17):6194. https://doi.org/10.3390/ijms21176194.
Lo EH, Ning M. Mechanisms and challenges in translational stroke research. J Investig Med. 2016;64(4):827–9. https://doi.org/10.1136/jim-2016-000104.
Zhang L, Wei W, Ai X, et al. Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-β/Smad2/3 pathway. Cell Death Dis. 2021;12(11):1068. https://doi.org/10.1038/s41419-021-04363-7.
Zhang ZG, Buller B, Chopp M. Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol. 2019;15(4):193–203. https://doi.org/10.1038/s41582-018-0126-4.
Dabrowska S, Andrzejewska A, Strzemecki D, et al. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats. J Neuroinflammation. 2019;16(1):216. https://doi.org/10.1186/s12974-019-1602-5.
Dong P, Li Q, Han H. HIF-1α in cerebralischemia (review). Mol Med Rep. 2022;25(2):41. https://doi.org/10.3892/mmr.2021.12557.
Caballero-Garrido E, Pena-Philippides JC, Lordkipanidze T, et al. In vivo inhibition of miR-155 promotes recovery after experimental mouse stroke. J Neurosci. 2015;35(36):12446–64. https://doi.org/10.1523/JNEUROSCI.1641-15.2015.
Ginouvès A, Ilc K, Macías N, et al. PHDs overactivation during chronic hypoxia “desensitizes” HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A. 2008;105(12):4745–50. https://doi.org/10.1073/pnas.0705680105.
Song S, Park JT, Na JY, et al. Early expressions of hypoxia-inducible factor 1alpha and vascular endothelial growth factor increase the neuronal plasticity of activated endogenous neural stem cells after focal cerebral ischemia. Neural Regen Res. 2014;9(9):912–8. https://doi.org/10.4103/1673-5374.133136.
Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 2020;40(9):1769–1777. https://doi.org/10.1177/0271678X20943823.
Milner R, Hung S, Wang X, et al. Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke. 2008;39(1):191–7. https://doi.org/10.1161/STROKEAHA.107.486134.
Kanazawa M, Kawamura K, Takahashi T, Miura M, Tanaka Y, Koyama M, et al. Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain. 2015;138(Pt 7):1932–48. https://doi.org/10.1093/brain/awv079.
Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. https://doi.org/10.1093/bioinformatics/bts635.
Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7(3):562–78. https://doi.org/10.1038/nprot.2012.016.
Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23(2):257–8. https://doi.org/10.1093/bioinformatics/btl567.
Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007.
Oosterhof N, Holtman IR, Kuil LE, et al. Identification of a conserved and acute neurodegeneration-specific microglial transcriptome in the zebrafish. Glia. 2017;65(1):138–49. https://doi.org/10.1002/glia.23083.
Matsuura Y, Wada H, Eguchi H, et al. Exosomal miR-155 derived from hepatocellular carcinoma cells under hypoxia promotes angiogenesis in endothelial cells. Dig Dis Sci. 2019;64(3):792–802. https://doi.org/10.1007/s10620-018-5380-1.
Nakai W, Yoshida T, Diez D, et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci Rep. 2016;6:33935. https://doi.org/10.1038/srep33935.
Kanazawa M, Kakita A, Igarashi H, et al. Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats. J Neurochem. 2011;116(6):957–65. https://doi.org/10.1111/j.1471-4159.2010.06860.x.
Kanazawa M, Igarashi H, Kawamura K, et al. Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. J Cereb Blood Flow Metab. 2011;31(6):1461–74. https://doi.org/10.1038/jcbfm.2011.9.
Balkaya M, Kröber J, Gertz K, Peruzzaro S, Endres M. Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods. 2013;213(2):179–87. https://doi.org/10.1016/j.jneumeth.2012.12.021.
Wang R, Liu Y, Ye Q, et al. RNA sequencing reveals novel macrophage transcriptome favoring neurovascular plasticity after ischemic stroke. J Cereb Blood Flow Metab. 2020;40(4):720–38. https://doi.org/10.1177/0271678X19888630.
Freytes DO, Kang JW, Marcos-Campos I, Vunjak-Novakovic G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem. 2013;114(1):220–9. https://doi.org/10.1002/jcb.24357.
Bennett ML, Bennett FC, Liddelow SA, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci USA. 2016;113(12):E1738-1746. https://doi.org/10.1073/pnas.1525528113.
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–80. https://doi.org/10.1016/j.cell.2006.10.018.
Jain AK, Barton MC. p53: emerging roles in stem cells, development and beyond. Development. 2018;145(8):dev158360. doi: https://doi.org/10.1242/dev.158360.
Wu C, Chen J, Chen C, et al. Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia. Sci Rep. 2015;5:16151. https://doi.org/10.1038/srep16151.
Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423(6938):409–14. https://doi.org/10.1038/nature01593.
Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987–91. https://doi.org/10.1038/nn.4338.
Masuda T, Sankowski R, Staszewski O, et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. 2019;566(7744):388–92. https://doi.org/10.1038/s41586-019-0924-x.
Arderiu G, Peña E, Aledo R, et al. MicroRNA-145 regulates the differentiation of adipose stem cells toward microvascular endothelial cells and promotes angiogenesis. Circ Res. 2019;125(1):74–89. https://doi.org/10.1161/CIRCRESAHA.118.314290.
Kurtzwald-Josefson E, Zeevi-Levin N, Rubchevsky V, et al. Cardiac fibroblast-induced pluripotent stem cell-derived exosomes as a potential therapeutic mean for heart failure. Int J Mol Sci. 2020;21(19):7215. https://doi.org/10.3390/ijms21197215.
Hong Y, He H, Jiang G, et al. miR-155–5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction. Aging Cell. 2020;19(4):e13128. https://doi.org/10.1111/acel.13128.
O’Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205(3):585–94. https://doi.org/10.1084/jem.20072108.
Hornick NI, Doron B, Abdelhamed S, et al. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci Signal. 2016;9(444):ra88. https://doi.org/10.1126/scisignal.aaf2797.
Bruning U, Cerone L, Neufeld Z, et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol. 2011;31(19):4087–96. https://doi.org/10.1128/MCB.01276-10.
Wang J, Zou Y, Du B, et al. SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling. Cell Death Dis. 2021;12(7):672. https://doi.org/10.1038/s41419-021-03958-4.
Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain. 2009;132(Pt 8):2239–51. https://doi.org/10.1093/brain/awp174.
van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun. 2011;25(7):1342–8. https://doi.org/10.1016/j.bbi.2011.03.021.
Froger N, Matonti F, Roubeix C, et al. VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons. Sci Rep. 2020;10(1):12409. https://doi.org/10.1038/s41598-020-68488-z.
Ogunshola OO, Antic A, Donoghue MJ, et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem. 2002;277(13):11410–5. https://doi.org/10.1074/jbc.M111085200.
Uchida H, Niizuma K, Kushida Y, et al. Human muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017;48(2):428–35. https://doi.org/10.1161/STROKEAHA.116.014950.
Närvä E, Pursiheimo JP, Laiho A, et al. Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels. PLoS One. 2013;8(11):e78847. https://doi.org/10.1371/journal.pone.0078847.
Cui P, Zhang P, Zhang Y, et al. HIF-1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells. FASEB J. 2020;34(4):5740–53. https://doi.org/10.1096/fj.201902829RR.
Takubo K, Goda N, Yamada W, et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7(3):391–402. https://doi.org/10.1016/j.stem.2010.06.020.
Shyh-Chang N, Daley GQ, Cantley LC. Stem cell metabolism in tissue development and aging. Development. 2013;140(12):2535–47. https://doi.org/10.1242/dev.091777.
Weinberger L, Ayyash M, Novershtern N, Hanna JH. Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol. 2016;17(3):155–69. https://doi.org/10.1038/nrm.2015.28.
Carmichael ST, Kathirvelu B, Schweppe CA, Nie EH. Molecular, cellular and functional events in axonal sprouting after stroke. Exp Neurol. 2017;287(Pt 3):384–94. https://doi.org/10.1016/j.expneurol.2016.02.007.
Jin K, Wang X, Xie L, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci USA. 2006;103(35):13198–202. https://doi.org/10.1073/pnas.0603512103.
Srivastava D, DeWitt N. In vivo cellular reprogramming: the next generation. Cell. 2016;166(6):1386–96. https://doi.org/10.1016/j.cell.2016.08.055.